Recent Headlines
Video Series Educates Families on Brain Tumors
In the Pediatric Brain Tumor Foundation’s new Family Support Learning Series videos, leading brain tumor experts discuss topics such as clinical trials, genetic susceptibility and molecular testing. - March 31, 2016 - Pediatric Brain Tumor Foundation
Hematogenix Laboratory Services, LLC Announces the Availability of FDA Approved PD-L1 Companion Diagnostic Tests
Hematogenix Laboratory Services Announces the Availability of PD-L1 Companion Diagnostic Tests for KEYTRUDA®, Merck's Anti-PD-1 Therapy for Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression on or after Platinum-Containing Chemotherapy as well as a PD-L1 Complementary Diagnostic Test to Support Bristol-Myers Squibb's OPDIVO® Anti-PD-1 Therapy for Non-Squamous Non-Small Cell Lung Cancer. - March 24, 2016 - Hematogenix
MiTeGen Announces Their In Situ-1 Crystallization Plates Have Been Selected for Use in Microgravity Crystallization Experiments Aboard the International Space Station
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced that a line of their products, the In Situ-1™ crystallization plates, will be used for research conducted on the International Space Station (ISS). - March 24, 2016 - MiTeGen, LLC
TrialX Launches America Walks, the First Mobile-Based Walking Study on iOS and Android Using Apple’s ResearchKit Technology
TrialX announced the launch of “America Walks,” a mobile based research study (http://trialx.com/americawalksstudy) to determine the walking behavior of Americans. The study is the first mobile app based study to be available on both iOS and Android devices. The America Walks App has been built using Apple’s ResearchKit Library and the team at TrialX has also ported the same for Android devices so that the app is available to a much larger population base. - March 24, 2016 - Applied Informatics
MFB Fertility, LLC Develops Only In-Home Test to Detect Progesterone
Research has shown that couples get pregnant faster when they know when exactly when ovulation takes place. Fertility monitors and ovulation predictor kits allow couples to track estrogen and luteinizing hormone (LH) levels from home. However, until now, there were no tests available to track progesterone. - March 23, 2016 - MFB Fertility, LLC
North County Health Services Opens New Location in Perris, California
North County Health Services (NCHS), a leading provider of health care, announces the opening of their newest health care facility. Families and individuals that are looking for medical attention can stop by NCHS’ newest location at 1675 N Perris Blvd, Perris, CA 92571 for all of their medical needs. - March 22, 2016 - NCHS
HPAPIs and Cytotoxic Drugs: The Growing Opportunity for Contract Manufacturers
Roots Analysis has announced the addition of HPAPIs and Cytotoxic Drugs Manufacturing Market, 2016-2026 (2nd edition) report to its portfolio. The report provides an extensive study of the contract manufacturing opportunity in this rapidly expanding market. The focus of this report is primarily to... - March 21, 2016 - Roots Analysis
NSF Funds NanoHybrids’ Improved Chemotherapy Delivery Platform
NSF SBIR grant to be used to advance nanoparticle platform for safe, effective, and controlled cancer drug delivery. - March 16, 2016 - NanoHybrids
Specialty CROs: The Future of R&D Outsourcing
Roots Analysis has announced the addition of Specialty CROs Market, 2016-2025 report to their offering. The report delivers a comprehensive study on Contract Research Organizations (CROs) that offer specialized sets of research capabilities/services, focused on a particular stage of clinical... - March 07, 2016 - Roots Analysis
National Sales Manager Announced for Stat-Technologies
Stat-Technologies, the premier distributor of point of care testing products, announced today that they have promoted Angela Hansen to National Sales Manager. Angela has been with Stat since 2008 as a territory representative and marketing manager for Oxygen, the paperless data collection... - March 05, 2016 - Stat-Technologies
Speaking of NEC Podcast Retrospective Launches February 28
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant NEC experts - neonatologists, clinicians and researchers - that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - February 27, 2016 - The Morgan Leary Vaughan Fund, Inc.
Clinical Research Forum Congratulates Co-Founder on U.S. Food and Drug Administration Appointment
Formed in 1996, the Clinical Research Forum convenes annually to allow industry leaders to discuss issues facing the field, best practices, and promote understanding and support for clinical research and its impact on health and healthcare. Through its activities, the Forum has increasingly played a national advocacy role in supporting broader interests and needs of clinical research. For more information, visit www.clinicalresearchforum.org. - February 26, 2016 - Clinical Research Forum
MR Solutions Brings New 3D, 1000X Magnification Imaging Modality to Preclinical Research
MR Solutions’ new 3D in vivo confocal microscope for use in preclinical research provides a magnification range of up to 1000 times, allowing researchers to examine cellular details within a live small animal eliminating the need for a surgical biopsy - saving time and substantially reducing costs. - February 24, 2016 - MR Solutions
ALPCO's New NT-proBNP ELISA Offers Cost Savings and Flexibility
ALPCO recently announced the release of its new NT-proBNP (1-76) ELISA, offering researchers investigating cardiovascular disease, kidney disease, and diabetes with a flexible, user friendly and cost effective tool. The assay is highly characterized to measure changes in levels of NT-proBNP, and... - February 23, 2016 - ALPCO
ALPCO Releases New Basophil Activation Test Validated for the Evaluation of Kinase Inhibitors in Early Drug Development
ALPCO has released its new InhibiScreen Basophil Activation Test (BAT) which was developed and validated specifically for the evaluation of kinase inhibitors during early drug development. - February 16, 2016 - ALPCO
Peptide Therapeutics: The Growing Hope for Metabolic Disorders
Roots Analysis has announced the addition of “Peptide Therapeutics in Metabolic Disorders, 2016-2025” report to its portfolio. The report provides a comprehensive study on the current market landscape and the future outlook of the evolving pipeline of peptide therapeutics that are being... - February 16, 2016 - Roots Analysis
Don Barbo Returns to VMG Health’s Business Valuation Practice
VMG Health welcomes back Don Barbo as a managing director in healthcare business valuation services. - February 13, 2016 - VMG Health
Fertility Preservation Network Welcomes Albuquerque, New Mexico Facility
Program greatly extends access to fertility preservation services - February 12, 2016 - ReproTech, LLC
Studies Use Epitope Diagnostics’ ELISA Kit to Establish Chromogranin A as a Potential Prognostic Marker in Prostate Cancer Patients Treated with Antiandrogens
Italian research group uses Epitope Diagnostics' Chromogranin A ELISA kit in study to determine CgA as a potential prognostic marker in castration-resistant prostate cancer patients treated in abiraterone or enzalutamide. - February 11, 2016 - Epitope Diagnostics, Inc.
Assessment Shows Nation’s Guard is Down Against Zika Virus and Mosquito-Borne Diseases
The Council of State and Territorial Epidemiologists (CSTE) supports President Barack Obama’s request of $1.8 billion to combat Zika virus. Declared a “global health emergency” by the World Health Organization, Zika virus increasingly threatens to spread local epidemics in the... - February 08, 2016 - Council of State and Territorial Epidemiologists
Bioquark Inc. and Revita Life Sciences to Collaborate on Regenerative Medicine Applications in Spinal Cord Injury
Bioquark Inc., a cutting edge life sciences company focused on the development of a novel biologic portfolio of products, services, and technologies for complex regeneration, disease reversion, and aging in humans, is entering a collaboration with India's Revita Life Sciences to advance translational opportunities in spinal cord injury repair. - February 06, 2016 - Bioquark Inc.
Vivonics Sells Artificial Lung Technology
Vivonics, Inc. announced today the sale of intellectual property and other assets related to its Artificial Lung technology to Lung Biotechnology PBC, a wholly-owned subsidiary of United Therapeutics Corporation. Vivonics’ development of the Artificial Lung technology was supported by the... - February 04, 2016 - Vivonics, Inc.
Speaking of NEC Podcast Featuring Dr. Corrine Hanson Recently Launched
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant NEC experts - neonatologists, clinicians and researchers - that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - February 02, 2016 - The Morgan Leary Vaughan Fund, Inc.
Genelex Receives Innovative Technology Designation from Vizient, Inc. for YouScript® Software
Genelex receives Innovative Technology Designation from Vizient, Inc. for YouScript® software that reduces ER visits & hospitalizations with improved, gene-based medication management. Designation recognizes the development of new solutions that benefit the health care industry. - January 30, 2016 - Genelex Corp
ALPCO's New Stool-Based Gastroenterology Assays and Extraction Method Can Improve Lab Sample Processing Time by Up to 86%
ALPCO recently launched a new panel of 13 stool-based gastroenterology assays that are all compatible with one single extraction step, allowing labs to improve sample processing time by up to 86%. - January 26, 2016 - ALPCO
MyTabib.com Connects You to Thousands of Medical Service Providers Worldwide
In January, a new medical portal MyTabib.com was launched providing a global healthcare search platform for patients. MyTabib.com offers patients the ability to search for clinics and doctors around the world in which they can compare cost procedures, book appointments right away, write comments and read real patient reviews in the comfort of their own home using the internet. - January 26, 2016 - MyTabib
Eagle Biosciences Announces the Launch of Functional Leptin ELISA
An Esoteric Kit for Measurement of Functional, Receptor Binding Leptin Levels in Serum or Plasma - January 25, 2016 - Eagle Biosciences, Inc.
Children’s Healthcare of Atlanta Received $1M Research Grant from Enduring Hearts
Children’s Healthcare of Atlanta has received a generous grant of $1,000,000 from the Enduring Hearts Foundation to fund cardiac research to enhance the lives of children needing heart transplantation. Some of the research funded will be that of Michael Davis, Ph.D., Director of the... - January 22, 2016 - Enduring Hearts
Asian Patent Acceptances Enhance Braasch Biotech Livestock Portfolio
New paradigm of using vaccines to enhance productivity in livestock, Braasch Biotech continues portfolio expansion - January 21, 2016 - Braasch Biotech LLC
International Society on Thrombosis and Haemostasis Releases New Clinical Core Curriculum to Aid Specialization of the Field
Journal of Thrombosis and Haemostasis publishes article on first internationally developed and reviewed Core Curriculum to guide clinical knowledge and training in the industry - January 21, 2016 - International Society on Thrombosis and Haemostasis (ISTH)
Microbiome Therapeutics Market: What’s the Future Potential?
The "Microbiome Therapeutics Market, 2015-2030" report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of products in this area. - January 18, 2016 - Roots Analysis
NanoHybrids Receives Grant Funding to Develop Breakthrough Technology in Cancer Detection and Diagnosis
NanoHybrids receives $225,000 from the National Cancer Institute (NCI) to develop breakthrough immunohistochemistry (IHC) technology. - January 10, 2016 - NanoHybrids
Now More Hope for Menopausal Women Experiencing the Physical and Emotional Impact of Painful Sex and Vaginal Dryness
New clinical data released on Prasterone (DHEA) Vaginal Ovules' positive effect on moderate to severe dyspareunia (Painful sex due to menopause) and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. - January 06, 2016 - Endoceutics
Speaking of NEC Podcast Featuring Dr. Sergio Golombek Recently Launches
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant NEC experts—neonatologists, clinicians and researchers—that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - January 01, 2016 - The Morgan Leary Vaughan Fund, Inc.
RFID and Enhanced UDI Tracking Updates Announced by Matrix IT, Medical Tracking Systems
Matrix IT, Medical Tracking Systems has announced the addition of RFID data capture and product enhancements to TRACTUS, the world's first sterile field UDI scanning and compliance platform. The platform now also integrates with any health or inventory management system in a hospital. - December 30, 2015 - Matrix Medical Tracking Systems
National Brain Tumor Society Opens New Funding Call for Its Oligodendroglioma Research Fund
Request for Applications seeks proposals for research on clinically relevant biomarkers for oligodendroglioma tumors, closes January 15, 2016. - December 18, 2015 - National Brain Tumor Society
MiTeGen Announces Diode Beam Stop License Agreement with Lawrence Berkeley Laboratory
MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed an exclusive licensing agreement with Lawrence Berkeley National... - December 17, 2015 - MiTeGen, LLC
Hemophilia Treatment ACE910 Bypasses Factor VIII Inhibitor in Affinity Biologicals Plasmas
Chugai Pharmaceutical's newly developed antibody ACE910 is a potential lifesaving treatment for Hemophilia A patients who have developed Factor VIII inhibitors. A first-in-human study (1) recently published by the American Society of Hematology indicates that ACE910 may be a safe and effective treatment for hemophilia A patients. - December 11, 2015 - Affinity Biologicals
Research Square Announces Video Summaries Solution to Help Researchers Communicate Their Work More Effectively
Research Square is partnering with MyScienceWork to offer engaging Video Summaries of research through the Polaris platform for universities and institutions. - December 11, 2015 - Research Square
Speaking of NEC Podcast Featuring Neonatal Ergonomics Expert Yamile Jackson Recently Launched
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant Necrotizing Enterocolitis (NEC) experts-neonatologists, clinicians and researchers-that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - December 03, 2015 - The Morgan Leary Vaughan Fund, Inc.
Product Spotlight: Introducing Factor V Coagulation Antibodies from Affinity Biologicals Inc.
The human heart is an amazing vessel that pumps blood throughout the body, but sometimes genetic mutations make it difficult for the cardiovascular system to function the way it should. Most people inherit the factor V protein gene, which promotes healthy blood clotting throughout the body. Unfortunately, some inherit the factor V Leiden gene, which does just the opposite and prevents blood from clotting normally. - November 30, 2015 - Affinity Biologicals
Dr. Sebag Brings the Floaters Discussion to Paris; Dr. Sebag Presents VMR's Floater Program Findings to the French Ophthalmology Society’s Annual Meeting in Paris, France
Dr. Sebag presented VMR's floater program findings at the French Ophthalmology Society’s annual meeting in Paris. He described curing floaters with a limited vitrectomy where only the offending vitreous tissue opacities are removed, as opposed to the entire vitreous. This outpatient operation is performed in just 10 minutes, without sutures, under local anesthesia. The effectiveness of this surgery has been published in worldwide and patients are increasingly requesting the treatment. - November 26, 2015 - VMR Institute
Aurora Scientific Inc. Unveils New Brand and Celebrates the Official Opening of a New Manufacturing Facility
On October 8, 2015, Aurora Scientific, a science and technology firm in Aurora, ON welcomed guests to celebrate the official launch of their new brand and grand opening of their new manufacturing facility. The event brought together local suppliers and dignitaries, valued clients, families and friends, marking a milestone for the growing company. - November 21, 2015 - Aurora Scientific Inc.
Monica Monici, the Scientific Director of ASAlaser Scientific Research Department, was Elected ELGRA President
Dr Monica Monici was appointed to a high office in the non-profit International Scientific Society devoted to the promotion of scientific research under various gravity conditions. - November 19, 2015 - ASA srl
Mercy Receives FDA Award for Medical Device Tracking
Collaborative agreement could be worth up to $5.2 million over three years. - November 18, 2015 - Mercy
EternoGen Aesthetics Completes Its Financing Round Securing $5MM to Commercialize Their First in Class Bio-Dermal Restoration Portfolio
EternoGen Aesthetics, LLC developer and manufacturer of advanced collagen scaffolds, announces the successful completion of its financial round. It has secured $5MM to prepare for the 2016 European commercialization of Rapid Polymerizing Collagen (RPC Pure-Collagen), the first of a rich pipeline of... - November 18, 2015 - EternoGen Aesthetics LLC
ReproTech Staff Discuss Fertility Preservation Options for Oncology Patients in Ft. Worth, TX
Cancer Care Services in Fort Worth, TX was the setting for a presentation entitled Fertility Preservation for the Oncology Patient. This program strives to promote education and extend access to fertility preservation services. - November 18, 2015 - ReproTech, LLC
Rite Aid First U.S. Drugstore Chain to Offer Harmonyx Genetic Testing to Customers
Tests help determine most effective medication therapy based on an individual’s genetic makeup - November 12, 2015 - Harmonyx Diagnostics
Successful Atlanta 8.5K Closes Event Season
Walkers and runners at the Nov. 7 Starry Night Atlanta 8.5K raised more than $120,000 to benefit the Pediatric Brain Tumor Foundation. More than 600 supporters gathered for the evening 8.5K at Centennial Olympic Park to honor local children with brain tumors, our Stars: Andrea, Anna, Ascher,... - November 12, 2015 - Pediatric Brain Tumor Foundation
Zenalux Announces Grants from the National Institute of Health for Cancer Screening
Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, has been awarded a grant from the National Institute of Health (NIH) to further develop the Zenascope® to screen for cancer by employing imaging and reducing operator error. Zenalux is also participating in an Academic Industry... - November 06, 2015 - Zenalux Biomedical, Inc.